3McDdonald TJ,Nilsson G,Vagne ,M, et al .A gastrin releasing peptide from the porcine non-antral gastric tissue [J],Gut,1978,19(9):767.
4Spindel ER,,Gibson BW, Reeve JR Jr,et al Cloning of CDNAs encoding amphibian bombesin:evidence for the relationship between and gasstyin-releasing peptide [J]. ProCNSUA,1990,87(24);9813-9817.
6Maruno K Yamaguchik, AbeK,et al,Immuncreactive gastrin- releasing peptide as a specific tumor markerin patients with small celllung carcinoma[J].cancerRES,1989,49(2):629.
7Micke P, HengstlerJG,rosR, et al.C-erbB-2 Expression in Small Cell Lurig Cancer is Associated with Poor Prognosis. Int.J Cencer .2009,92(4):474.
10Crombach G Serharl A ,Viehtuehen M, et al. Deteetionof Squamous cell car cinoma antigen in nomal peitherlia and insqualors cancer,1989;63:1337-1342 the uterine cervix.
3[2]Alatas F,Alatas O,Metintas M.Diagnostic value of CEA,CA153,CA19-9,CYFRA 21-1,NSE and TSA assay inpleural effusions.Lung cancer,2001,31(1):9.
4[3]Dize M,Torres A,ollan M.Prognostic significance of serum CA125 assay inpatients with NSCLC.1994,73(5):1386.
5[4]Nilesson O,Jobassom.A comparison with CEA,CA50 and CA19-9.Br J Cancer 1994,65:215.
6[5]Kawa,Tokco,Hasebe.Comparative study of CA424 and CA19-9for the diagnosis of pancreatic cancer.Br J Cancer,1994,70:481.
7[6]Pujol JL,et al.Serum CYFRA21-1 as a marker of lung cancer.Br J Cancer,1993,67:1423
8[1]Ando S, Kimura H, Iwai N, et al. Optimal combination of seven tumor markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Anticancer Research, 2001, 21 (4) :3085
9[2]Niklinski J, Furman M, Burzyowski T. Preoperative CYFRA21-1 level as aprognostic in resected primary squamous cell lung cancer. B J Cancer, 1996, 74:956
10[3]Antonio LP, Antonio JT, Marisa M. Quantitative analysis of CEA, SCC, CA125, and CA50 cytosolic content in NSCLC.Cancer, 1996, 73 (9) :2305
